机构：[1]Department of Ultrasound, Ruijin Hospital, School of Medicine,Shanghai Jiaotong University, Shanghai 200025, China[2]Institute of Ultrasound in Medicine, The Affiliated SichuanProvincial People’s Hospital of Electronic Science andTechnology University of China, Chengdu 610071, China[3]Department of Diagnostic and Therapeutic Ultrasound, TianjinMedical University Cancer Institute and Hospital, NationalClinical Research Center of Cancer, Key Laboratory of CancerPrevention and Therapy, Tianjin 300060, China[4]Department of Biostatistics, Institute of Medical Sciences,Shanghai Jiaotong University School of Medicine,Shanghai 200025, China[5]Department of Ultrasound, SunYat-sen Memorial Hospital,SunYat-sen University, Guangzhou 510120, China中山大学附属第二医院[6]Department of Ultrasound, Peking Union Medical CollegeHospital, Beijing 100730, China[7]Department of Ultrasound, Beijing Friendship Hospital, CapitalMedical University, Beijing 100050, China首都医科大学附属北京友谊医院[8]Department of Ultrasound, Peking University Third Hospital,Beijing 100191, China[9]Department of Ultrasound, Peking University InternationalHospital, Beijing 102206, China[10]Department of Ultrasound, West China Hospital of SichuanUniversity, Chengdu 610041, China[11]Department of Ultrasound, The Affiliated Sichuan ProvincialPeople’s Hospital of Electronic Science and TechnologyUniversity of China, Chengdu 610071, China四川省人民医院[12]Department of Ultrasound, Sichuan Cancer Hospital,Chengdu 610041, China四川省肿瘤医院[13]Department of Ultrasound, Fudan University Shanghai CancerCenter, Shanghai 200032, China[14]Department of Oncology, Shanghai Medical College, FudanUniversity, Shanghai 200032, China[15]Department of Ultrasound, Shanghai First People’s HospitalAffiliated to Shanghai Jiaotong University School of Medicine,Shanghai 201620, China[16]Department of Ultrasound, Fujian Medical University UnionHospital, Fuzhou 350001, China[17]Department of Ultrasound, Nanfang Hospital of Southern MedicalUniversity, Guangzhou 510515, China[18]Department of Ultrasound, The Third Affiliated Hospital ofKunming Medical University, Yunnan Cancer Hospital,Kunming 650031, China[19]Department of Ultrasound, General Hospital of Ningxia MedicalUniversity, Yinchuan 750021, China[20]Department of Ultrasound, The First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052, China[21]Department of Ultrasound, Henan Provincial People’s Hospital,Zhengzhou 450003, China[22]Department of Ultrasound, The Second Affiliated Hospital ofHarbin Medical University, Harbin 150086, China[23]Department of Ultrasound, Tongji Hospital, Tongji MedicalColloge, Huazhong University of Science and Technology,Wuhan 430030, China华中科技大学同济医学院附属同济医院
Thyroid nodules are very common all over the world, and China is no exception. Ultrasound plays an important role in determining the risk stratification of thyroid nodules, which is critical for clinical management of thyroid nodules. For the past few years, many versions of TIRADS (Thyroid Imaging Reporting and Data System) have been put forward by several institutions with the aim to identify whether nodules require fine-needle biopsy or ultrasound follow-up. However, no version of TIRADS has been widely adopted worldwide till date. In China, as many as ten versions of TIRADS have been used in different hospitals nationwide, causing a lot of confusion. With the support of the Superficial Organ and Vascular Ultrasound Group of the Society of Ultrasound in Medicine of the Chinese Medical Association, the Chinese-TIRADS that is in line with China's national conditions and medical status was established based on literature review, expert consensus, and multicenter data provided by the Chinese Artificial Intelligence Alliance for Thyroid and Breast Ultrasound.
第一作者机构：[1]Department of Ultrasound, Ruijin Hospital, School of Medicine,Shanghai Jiaotong University, Shanghai 200025, China
推荐引用方式(GB/T 7714)：
JianQiao Zhou,LiXue Yin,Xi Wei,et al.2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.[J].ENDOCRINE.2020,70(2):256-279.doi:10.1007/s12020-020-02441-y.
APA：
JianQiao Zhou,LiXue Yin,Xi Wei,Sheng Zhang,YanYan Song...&WeiWei Zhan.(2020).2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS..ENDOCRINE,70,(2)
MLA：
JianQiao Zhou,et al."2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.".ENDOCRINE 70..2(2020):256-279
